RSS
ZLTQ

Rosenblum Silverman Sutton’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Rosenblum Silverman Sutton’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-44,110
Closed -$2.45M – 66
2017
Q1 		$2.45M Sell
44,110
-3,155
-7% -$158K 1.04% 38
2016
Q4 		$2.06M Sell
47,265
-1,000
-2% -$40.3K 0.97% 39
2016
Q3 		$1.89M Sell
48,265
-500
-1% -$17.9K 0.87% 37
2016
Q2 		$1.33M Buy
+48,765
New +$1.37M 0.64% 44
2015
Q4 		$1.55M Sell
54,450
-2,550
-4% -$80.5K 0.71% 45
2015
Q3 		$1.83M Hold
57,000
– – 0.87% 40
2015
Q2 		$1.68M Buy
+57,000
New +$1.72M 0.67% 45
2014
Q4 		$1.73M Sell
61,900
-1,375
-2% -$35.8K 0.74% 42
2014
Q3 		$1.43M Buy
63,275
+8,350
+15% +$165K 0.64% 50
2014
Q2 		$834K Buy
54,925
+3,625
+7% +$62K 0.39% 53
2014
Q1 		$1.01M Buy
51,300
+1,500
+3% +$29.3K 0.48% 56
2013
Q4 		$942K Buy
49,800
+10,100
+25% +$144K 0.45% 58
2013
Q3 		$358K Buy
+39,700
New +$295K 0.19% 60

Other funds holding ZLTQ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Rosenblum Silverman Sutton's ZLTQ Position: Q2 2017 in Review

Rosenblum Silverman Sutton sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 44,110 shares — an estimated $2.45M sold.

Rosenblum Silverman Sutton first reported a position in ZLTQ in Q3 2013 and held it in 13 quarters. The position peaked at $2.45M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

  • Rosenblum Silverman Sutton reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Rosenblum Silverman Sutton sold 44,110 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $2.45M.
  • Rosenblum Silverman Sutton first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2013 and held it in 13 quarters.
  • Rosenblum Silverman Sutton's ZELTIQ Aesthetics, Inc. position peaked at $2.45M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on Rosenblum Silverman Sutton's 13F filing for Q2 2017, filed 9 Aug 2017.